ASAS-EULAR recommandations for management of axial spondyloarthritis: 2022 update (2023)
https://pubmed.ncbi.nlm.nih.gov/36270658/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34750246/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34534275/

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS (2018)
https://pubmed.ncbi.nlm.nih.gov/29038299/

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28087505/

Improved clinical, functional and work outcomes in spondyloarthritides during real-life adalimumab treatment in central-eastern Europe (2016)
https://pubmed.ncbi.nlm.nih.gov/27417564/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016)
https://pubmed.ncbi.nlm.nih.gov/27752358/

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis (2014)
https://pubmed.ncbi.nlm.nih.gov/24832835/

Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study (2013)
https://pubmed.ncbi.nlm.nih.gov/23065731/

Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitis (2012)
https://pubmed.ncbi.nlm.nih.gov/22006544/

Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study (2012)
https://pubmed.ncbi.nlm.nih.gov/22653382/

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (2011)
https://pubmed.ncbi.nlm.nih.gov/21540199/

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE) (2011)
https://pubmed.ncbi.nlm.nih.gov/21317434/

Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy (2008)
https://pubmed.ncbi.nlm.nih.gov/18464306/

ASAS/EULAR recommendations for the management of ankylosing spondylitis (2006)
https://pubmed.ncbi.nlm.nih.gov/16126791/

[The role of biologic agents in the therapy of ankylosing spondylitis] (2006)
https://pubmed.ncbi.nlm.nih.gov/16898082/

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis (2006)
https://pubmed.ncbi.nlm.nih.gov/16968715/

[Hungarian adaptation of a disease-specific quality-of-life questionnaire in patients with ankylosing spondylitis] (2002)
https://pubmed.ncbi.nlm.nih.gov/12221995/

Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis (2001)
https://pubmed.ncbi.nlm.nih.gov/11208503/

Cardiac and cardiopulmonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis (1988)
https://pubmed.ncbi.nlm.nih.gov/3396245/

[Cardiac changes found in patients with ankylosing spondylarthritis] (1985)
https://pubmed.ncbi.nlm.nih.gov/3975021/

HLA-B27-associated spondylarthritis in chronic brucellosis (1978)
https://pubmed.ncbi.nlm.nih.gov/76040/